Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing
Journal of Clinical Microbiology · 14.05.2025 · 63 (5)
DOI: 10.1128/jcm.01819-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 14.05.2025. Verfasst von Vincent Streva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Northwell Heath, New York, New York, USA. Hauptthemen laut MEDLINE: Blood Culture, Gram-Negative Bacteria, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accurate and rapid antimicrobial susceptibility test (AST) results from positive blood cultures are crucial for patient care and combatting antimicrobial resistance. Although recent advancements in rapid direct-from-positive blood culture (PBC) identification platforms have enabled the provision of species-level identification and some resistance marker information within hours after blood culture positivity, AST results required for clinical decision-making often require 48 h after blood culture positivity. This study evaluated the Selux next-generation phenotyping system, including an automated PBC Separator and the Selux AST system in a multicenter clinical trial for their ability to perform AST directly from PBCs for gram-negative bacilli. The PBC separator produces McFarland equivalent inocula from positive blood cultures within 1 h, facilitating direct processing on the Selux AST system. The study evaluated 162 fresh clinical PBC samples, 307 seeded clinical samples, and 87 seeded challenge samples across 4 sites for each of the 17 antimicrobials included in the panel. The results demonstrate that the Selux system’s clinical performance, reproducibility, and analytical performances are consistent when using positive blood cultures held for up to 16 h after positivity on the BACTEC and BacT/ALERT 3D and BacT/ALERT VIRTUO blood culture systems, including all major BACTEC and BacT/ALERT blood culture bottle types. These findings suggest that the PBC Separator with the Selux AST system is a valuable addition to the arsenal of tools available for rapid sepsis diagnosis and management. IMPORTANCE Technologies that consistently and substantially shorten the time between blood bottle positivity, organism identification, and complete AST results are crucial for ensuring that antimicrobial therapy can be tailored. The Selux PBC Separator and the Selux AST system perform rapid AST directly from positive blood culture bottles. This substantially shortens the gap between obtaining a positive blood bottle and organism identification and the availability of a fully actionable AST result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northwell Heath, New York, New York, USA.
- Element, Acton, Massachusetts, USA.
- The Center for Advanced Laboratory Medicine, Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
- Element Iowa City (JMI Laboratories), North Liberty, Iowa, USA.
- Selux Diagnostics, Charlestown, Massachusetts, USA.
ORCID-Profile: Vincent Streva, Alamelu Chandrasekaran, Eric Stern, Gregory J Berry
Zitieren
APA
Streva, V., Gajewski, J., Pento, J., Chandrasekaran, A., Green, M., Lindley, J., Huband, M., El Ganbour, A., Roberts, K., Flentie, K., Sherman, J., Stern, E., & Berry, G. J. (2025). Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing. Journal of Clinical Microbiology, 63(5). https://doi.org/10.1128/jcm.01819-24
Vancouver
Streva V, Gajewski J, Pento J, Chandrasekaran A, Green M, Lindley J, et al. Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing. Journal of Clinical Microbiology. 2025;63(5). doi:10.1128/jcm.01819-24
BibTeX
@article{Streva2025,
author = {Streva, Vincent and Gajewski, Joseph and Pento, Jacqueline and Chandrasekaran, Alamelu and Green, Matt and Lindley, Jill and Huband, Micahel and El Ganbour, Asmae and Roberts, Kristen and Flentie, Kelly and Sherman, Jingzi and Stern, Eric and Berry, Gregory J},
title = {Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing},
journal = {Journal of Clinical Microbiology},
year = {2025},
volume = {63},
number = {5},
doi = {10.1128/jcm.01819-24}
}
EUVIMED